143 related articles for article (PubMed ID: 20472104)
1. Intellectual property, commercial needs and humanitarian benefits: must there be a conflict?
Krattiger A
N Biotechnol; 2010 Nov; 27(5):573-7. PubMed ID: 20472104
[TBL] [Abstract][Full Text] [Related]
2. GATT and the gap: how to save lives.
James JS
AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
[TBL] [Abstract][Full Text] [Related]
3. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
4. [Inequalities of access to care and in participation in research on a worldwide level: ethical problems].
France. Comite consultatif national d'ethique pour les sciences de la vie et de la sante
J Int Bioethique; 2005; 16(3-4):152-3. PubMed ID: 17058809
[No Abstract] [Full Text] [Related]
5. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
6. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.
Rovira J
Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921
[No Abstract] [Full Text] [Related]
7. Who shall live when not all can live? Intellectual property in accessing and benefit-sharing influenza viruses through the World Health Organisation.
Lawson C
J Law Med; 2011 Mar; 18(3):554-76. PubMed ID: 21528740
[TBL] [Abstract][Full Text] [Related]
8. Needed: a new system of intellectual property rights.
Thurow LC
Harv Bus Rev; 1997; 75(5):94-103. PubMed ID: 10170334
[TBL] [Abstract][Full Text] [Related]
9. Intellectual property. Plants and intellectual property: an international appraisal.
Koo B; Nottenburg C; Pardey PG
Science; 2004 Nov; 306(5700):1295-7. PubMed ID: 15550646
[No Abstract] [Full Text] [Related]
10. The Inter-Governmental Working Group on Public Health, Innovation and Intellectual Property (IGWG)--the way ahead.
Satyanarayana K; Srivastava S
Indian J Med Res; 2008 Nov; 128(5):577-80. PubMed ID: 19179674
[No Abstract] [Full Text] [Related]
11. Global health and Brazilian foreign policy: the negotiations on innovation and intellectual property.
Lima JHDS
Cien Saude Colet; 2017 Jul; 22(7):2213-2221. PubMed ID: 28724003
[TBL] [Abstract][Full Text] [Related]
12. TRIPS-plus and access to medicines in China.
Chen J; Nie X; Yao P; Shi L
J Public Health Policy; 2013 May; 34(2):226-38. PubMed ID: 23552834
[TBL] [Abstract][Full Text] [Related]
13. Access to vaccine technologies in developing countries: Brazil and India.
Milstien JB; Gaulé P; Kaddar M
Vaccine; 2007 Nov; 25(44):7610-9. PubMed ID: 17913312
[TBL] [Abstract][Full Text] [Related]
14. Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries.
Andanda PA
J Med Ethics; 2008 Mar; 34(3):171-9. PubMed ID: 18316458
[TBL] [Abstract][Full Text] [Related]
15. Patent laws. Report urges leeway for developing world.
Couzin J; Bagla P
Science; 2002 Sep; 297(5588):1791. PubMed ID: 12228696
[No Abstract] [Full Text] [Related]
16. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
Cohen-Kohler JC; Forman L; Lipkus N
Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
[TBL] [Abstract][Full Text] [Related]
17. CIPIH report: main recommendations.
Bull World Health Organ; 2006 May; 84(5):351. PubMed ID: 16710542
[No Abstract] [Full Text] [Related]
18. Eliminating neglected diseases in poor countries: a conversation with Andrew Witty. Interview by Susan Dentzer.
Witty A
Health Aff (Millwood); 2009; 28(3):w411-6. PubMed ID: 19299425
[No Abstract] [Full Text] [Related]
19. Health GAP coalition--new group for international treatment access.
AIDS Treat News; 1999 Mar; (No 315):5-6. PubMed ID: 11366560
[TBL] [Abstract][Full Text] [Related]
20. Essential drugs in the new international economic environment.
Velásquez G; Boulet P
Bull World Health Organ; 1999; 77(3):288-92. PubMed ID: 10212525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
